Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ENvue Medical (FEED) EPS (Weighted Average and Diluted) (2022 - 2025)

Historic EPS (Weighted Average and Diluted) for ENvue Medical (FEED) over the last 4 years, with Q3 2025 value amounting to -$0.91.

  • ENvue Medical's EPS (Weighted Average and Diluted) rose 7443.82% to -$0.91 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.31, marking a year-over-year increase of 9337.34%. This contributed to the annual value of -$13.73 for FY2024, which is 4113.44% up from last year.
  • According to the latest figures from Q3 2025, ENvue Medical's EPS (Weighted Average and Diluted) is -$0.91, which was up 7443.82% from -$1.03 recorded in Q2 2025.
  • ENvue Medical's EPS (Weighted Average and Diluted)'s 5-year high stood at $3.98 during Q1 2025, with a 5-year trough of -$27.18 in Q2 2024.
  • Over the past 4 years, ENvue Medical's median EPS (Weighted Average and Diluted) value was -$0.92 (recorded in 2022), while the average stood at -$2.97.
  • Over the last 5 years, ENvue Medical's EPS (Weighted Average and Diluted) had its largest YoY gain of 45522.39% in 2024, and its largest YoY loss of 408153.85% in 2024.
  • Over the past 4 years, ENvue Medical's EPS (Weighted Average and Diluted) (Quarter) stood at -$1.45 in 2022, then crashed by 252.32% to -$5.11 in 2023, then fell by 3.78% to -$5.3 in 2024, then surged by 82.84% to -$0.91 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.91 for Q3 2025, versus -$1.03 for Q2 2025 and $3.98 for Q1 2025.